Advertisement

 

 

Hydrophobic Nanoparticles Reduce the β-Sheet Content of SEVI Amyloid Fibrils and Inhibit SEVI-Enhanced HIV Infectivity.

Hydrophobic Nanoparticles Reduce the β-Sheet Content of SEVI Amyloid Fibrils and Inhibit SEVI-Enhanced HIV Infectivity.
Author Information (click to view)

Sheik DA, Chamberlain JM, Brooks L, Clark M, Kim YH, Leriche G, Kubiak CP, Dewhurst S, Yang J,


Sheik DA, Chamberlain JM, Brooks L, Clark M, Kim YH, Leriche G, Kubiak CP, Dewhurst S, Yang J, (click to view)

Sheik DA, Chamberlain JM, Brooks L, Clark M, Kim YH, Leriche G, Kubiak CP, Dewhurst S, Yang J,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Langmuir : the ACS journal of surfaces and colloids 2017 03 0133(10) 2596-2602 doi 10.1021/acs.langmuir.6b04295

Abstract

Semen-derived enhancer of virus infection (SEVI) fibrils are naturally abundant amyloid aggregates found in semen that facilitate viral attachment and internalization of human immunodeficiency virus (HIV) in cells, thereby increasing the probability of infection. Mature SEVI fibrils are composed of aggregated peptides exhibiting high β-sheet secondary structural characteristics. Herein, we show that polymers containing hydrophobic side chains can interact with SEVI and reduce its β-sheet content by ∼45% compared with the β-sheet content of SEVI in the presence of polymers with hydrophilic side chains, as estimated by polarization modulation-infrared reflectance absorption spectroscopy measurements. A nanoparticle (NP) formulation of this hydrophobic polymer reduced SEVI-mediated HIV infection in TMZ-bl cells by 60% compared with the control treatment. Although these NPs lacked specific amyloid-targeting groups, thus requiring high concentrations to observe biological activity, the use of hydrophobic interactions to alter the secondary structure of amyloids represents a useful approach to neutralizing the SEVI function. These results could, therefore, have general implications in the design of novel materials that can modify the activity of amyloids associated with a variety of other neurological and systemic diseases.

Submit a Comment

Your email address will not be published. Required fields are marked *

1 + seven =

[ HIDE/SHOW ]